Retractable Technologies (NYSE:RVP – Get Free Report) and Beyond Air (NASDAQ:XAIR – Get Free Report) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, profitability, risk, analyst recommendations, dividends, valuation and institutional ownership.
Profitability
This table compares Retractable Technologies and Beyond Air’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Retractable Technologies | -41.11% | -17.15% | -9.33% |
| Beyond Air | -432.99% | -350.00% | -101.34% |
Earnings & Valuation
This table compares Retractable Technologies and Beyond Air”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Retractable Technologies | $37.15 million | 0.54 | -$7.01 million | ($0.21) | -3.21 |
| Beyond Air | $7.68 million | 0.65 | -$33.25 million | ($88.00) | -0.08 |
Retractable Technologies has higher revenue and earnings than Beyond Air. Retractable Technologies is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks.
Risk and Volatility
Retractable Technologies has a beta of 1.22, meaning that its stock price is 22% more volatile than the S&P 500. Comparatively, Beyond Air has a beta of 0.23, meaning that its stock price is 77% less volatile than the S&P 500.
Institutional & Insider Ownership
7.6% of Retractable Technologies shares are owned by institutional investors. Comparatively, 31.5% of Beyond Air shares are owned by institutional investors. 59.5% of Retractable Technologies shares are owned by insiders. Comparatively, 10.0% of Beyond Air shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Analyst Ratings
This is a breakdown of current ratings and target prices for Retractable Technologies and Beyond Air, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Retractable Technologies | 0 | 0 | 0 | 0 | 0.00 |
| Beyond Air | 1 | 0 | 2 | 0 | 2.33 |
Beyond Air has a consensus price target of $200.00, suggesting a potential upside of 2,767.38%. Given Beyond Air’s stronger consensus rating and higher possible upside, analysts clearly believe Beyond Air is more favorable than Retractable Technologies.
Summary
Retractable Technologies beats Beyond Air on 8 of the 14 factors compared between the two stocks.
About Retractable Technologies
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. It distributes its products through general line and specialty distributor; international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.
About Beyond Air
Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.
Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
